About a third of breast tumours that are diagnosed as triple-negative overexpress the epidermal growth factor receptor (EGFR) and most of these tumours also show upregulation of the PI3K/AKT signalling pathway. The gene discussed is PIK3CA; the disease is breast neoplasm.